|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: Brain Aminopeptidases and Hypertension
Inmaculada Banegas
Unit of Physiology, University of Jaén, Spain
Isabel Prieto
Unit of Physiology, University of Jaén, Spain
Francisco Vives
Department of Physiology, University of Granada, Spain
Francisco Alba
Federico Oloriz Institute of Neuroscience, Granada, Spain
Marc de Gasparo
MGConsulting Co. Rue es Planches 5, 2842 Rossemaison, Switzerland
Ana Belen Segarra
Unit of Physiology, University of Jaén, Spain
Francisco Hermoso
Unit of Physiology, University of Jaén, Spain
Raquel Durán
Department of Physiology, University of Granada, Spain
Manuel Ramírez
Unit of Physiology, University of Jaén, Spain, msanchez{at}ujaen.es
The brain aminopeptidases that participate in the enzymatic cascade of the renin-angiotensin system play a major role in blood pressure (BP) control, and their study offers new perspectives for the understanding of central BP control and the treatment of hypertension. In this system, angiotensin II is converted to angiotensin III (Ang III) by glutamyl aminopeptidase (GluAP) and Ang III is further metabolised to angiotensin IV by alanyl aminopeptidase or arginine-aminopeptidase. It is now clear that Ang III is the key active form of the central angiotensins, exerting tonic stimulatory control over BP Therefore, the development of GluAP inhibitors as potential antihypertensive agents offers new perspectives for therapy. Brain aspartyl JR aminopeptidase, which converts angiotensin I to angiotensin 2-10, is also a possible target for antihypertensive therapy because of its potential role in BP control. Finally, since changes in BP levels, that paralleled changes in brain and plasma aminopeptidase activities, were observed after unilateral lesions of the nigrostriatal system, brain asymmetry, aminopeptidase activities and BP control appear to be related, resulting their interplay in an asymmetrical neuroendocrine response that differentially affect BP control.The study of this interaction may contribute to our understanding of how the brain controls BP
Key Words: Aminopeptidases • Angiotensin • Brain • Hypertension
References
- Ferdinand KC Update in pharmacologic treatment of hypertension. Cardiol Clin 2001;19:279-94.[CrossRef][Medline]
[Order article via Infotrieve]
- Veerasingham SJ, Raizada MK Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003;139:191-202.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Barret AJ, Rawlings ND, Woessner JF (eds.) Handbook of Proteolytic Enzymes. London: Academic Press, 1998.
- Wilk S., Wilk E., Magnusson RP Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase. J Biol Chem 1998;273:15961-70.[Abstract/Free Full Text]
- Albiston AL, McDowall SG, Matsacos D. et al. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol C O hem 2001; 276:48623-6.
- Wright JW, Harding JW Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Brain Res Rev 1997;25:96-124.[CrossRef][Medline]
[Order article via Infotrieve]
- Reaux A., Fournie-Zaluski MC, David C., Zini S., Roques BP, Corvol P., Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 1999;96:13415-20.[Abstract/Free Full Text]
- Min L., Sim MK, Xu XG Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells. Regul Pept 2000;95:93-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Blair-West JR, Coghlan JP, Denton DA et al. A dose-response comparison of the actions of angiotensin II and angiotensin III in sheep. J Endocrinol 1980;87:409-17.[Abstract/Free Full Text]
- Li Q., Feenstra M., Pfaffendorf M., Eijsman L., van Zwieten PA Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J Cardiovasc Pharmacol 1997;29:451-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- De Gasparo M., Whitebread S., Bottari SP, Levens NR Medicinal Chemistry of the Renin Angiotensin System. PBMWM Timmermans & RR Wexler (eds), Elsevier Science BV, 1994.
- Garcia-Sainz JA, Martinez-Alfaro M., Romero-Avila MT, Gonzalez-Espinosa C. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver. J Endocrinol 1997;154:133-8.[Abstract/Free Full Text]
- Chai SY, Fernando R., Peck G. et al. The angiotensin IV/AT4 receptor. Cell Mol Life Sci 2004;61:2728-37.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Coleman JKM, Krebs LT, Hamilton TA et al. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin-IV-induced renal cortical blood flow changes in rats. Peptides 1998;19:269-77.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wright JW, Harding JW The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning and memory. Prog Neurobiol 2004;72:263-93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lim BC, Sim MK Actions of des-Asp angiotensin I on the aortic rings of the normo- and hypertensive rats. Clin Exp Hypertens 1998;20:105-17.[Web of Science][Medline]
[Order article via Infotrieve]
- Wright JW, Sullivan MJ, Harding JW Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats. Neurosci Lett 1985;61:351-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats. J Hypertens Suppl 1986;4: S408-S411.[Medline]
[Order article via Infotrieve]
- Wright JW, Sullivan MJ, Bredl CR, Hanesworth JM, Cushing LL, Harding JW Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat. J Neurochem 1987;49:651-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jensen LL, Harding JW, Wright JW Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains. Brain Res 1989;490:48-55.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wright JW, Jensen LL, Cushing LL, Harding JW Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats. Hypertension 1989;13:910-15.[Abstract/Free Full Text]
- Wright JW, Mizutani S., Murray CE, Amir HZ, Harding JW Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat. J Hypertens 1990;8:969-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zini S., Fournie-Zaluski MC, Chauvel E., Roques BP, Corvol P., Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 1996;93:11968-73.[Abstract/Free Full Text]
- Prieto I., Martínez JM, RamÌrez MJ et al. Aminopeptidase activities after water deprivation in male and female rats. Regul Pept 2001;101:189-94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wilson WL, Roques BP, Llorens-Cortes C., Speth RC, Harding JW, Wright JW Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Res 2005;1060:108-17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zini S., Masdehors P., Lenkei Z. et al. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 1997;78:1187-93.[CrossRef][Medline]
[Order article via Infotrieve]
- Fournie-Zaluski MC, Fassot C., Valentin B. et al. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci USA 2004;101: 7775-80.[Abstract/Free Full Text]
- Rozenfeld R., Muller L., El Messari S., Llorens-Cortes C. The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase. J Biol Chem 2004;279:43285-95.[Abstract/Free Full Text]
- Iturrioz X., Reaux A., Llorens-Cortes C. Aminopeptidase inhibitors as anti-hypertensive drugs In: Aminopeptidases in biology and disease. Hooper NM and Lendeckel U. (eds.) New York: Kluwer Academic/Plenum Publishers, pp 229-50, 2004.
- Inguimbert N., Coric P., Dhotel H. et al. Synthesis and in vitro activities of new non-peptidic AP A inhibitors. J Pept Res 2005;65:175-88.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sim MK, Qiu XS Formation of des-Asp-angiotensin I in the hypothalamic extract of normo- and hypertensive rats. Blood Press 1994;3:260-4.[Medline]
[Order article via Infotrieve]
- Hermann K., Phillips MI, Raizada MK Metabolism of angiotensin peptides by neuronal and glial cultures from rat brain. J Neurochem 1989;52:863-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ramírez M., Arechaga G., García S., Sánchez B., De Gandarias JM Mn2(+)-activated aspartate aminopeptidase activity, subcellular localization in young and adult rat brain. Brain Res 1990;522:165-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Arechaga G., Sanchez B., Alba F., Luna JD, Prieto I., Martinez JM, Ramírez M. Developmental changes of soluble and membrane-bound aspartate aminopeptidase activities in rat brain. J Physiol Biochem 1996;52:149-54.[Web of Science]
- Ramírez M., Sanchez B., Arechaga G. et al. Daily rhythm of aspartate aminopeptidase activity in the retina, pineal gland and occipital cortex of the rat. Neuroendocrinology 1992;56:926-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Prieto I., Segarra AB, Vargas F., Alba F., de Gasparo M., Ramirez M. Angiotensinase activity in hypothalamus and pituitary of hypothyroid, euthyroid and hyperthyroid adult male rats. Horm Metab Res 2003;35:279-81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Prieto I., Hermoso F., de Gasparo M. et al. Angiotensinase activities in the kidney of renovascular hypertensive rats. Peptides 2003;24:755-60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mustafa MR, Dharmani M., Kunheen NK, Sim MK Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats. Regul Pept 2004;120:15-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Banegas I., Prieto I., Vives F. et al. Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine. Neuroendocrinology 2004;80:219-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Banegas I., Barrero F., Morales B. et al. Plasma aminopeptidase activities in Parkinson's disease. Horm Metab Res (in press).
Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 3,
129-134 (2006)
DOI: 10.3317/jraas.2006.021
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
